Get started
Work

Nimotuzumab combined with paclitaxel and cisplatin as first-line treatment for metastatic esophageal squamous cell carcinoma: A prospective, multicenter, double-blind, randomized controlled clinical study.

Year: 2026
Type: conference-abstract
DOI: 10.1200/jco.2026.44.16_suppl.4055
Authors: Zhihao Lu, Miaozhen Qiu, Bin Hu, Lianke Liu, Tianshu Liu, Lei Chen, Li Enxiao, Tao Sun, Xiaohong Wu, Yiping Zhang, Dai Guanghai, Chunjiao Wu, Xiaoyan Lin, Xiaobing Chen, Ningju Wang, Hongming Pan, Yu-Xian Bai, Xiuli Yang, Lin Shen, Ruihua Xu
Institutions: Peking University Cancer Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, University of Science and Technology of China, Jiangsu Province Hospital, Fudan University, Zhongshan Hospital, Cancer Hospital of Shantou University Medical College, First Affiliated Hospital of Xi'an Jiaotong University, Liaoning Cancer Hospital & Institute, Wuxi Fourth People's Hospital, Zhejiang Cancer Hospital, Chinese PLA General Hospital, Chinese People's Liberation Army, Jilin Province Tumor Hospital, Union Hospital, Henan Cancer Hospital, Ningxia Medical University, Ningxia Medical University General Hospital, Sir Run Run Shaw Hospital, Zhejiang University, Third Affiliated Hospital of Harbin Medical University, Nanyang Medical College
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: closed
OpenAlex ID: W7162492015
Cites:
Cited by:
Related to: